Sepracor Pharmaceuticals changes company name to Sunovion

Sunovion Pharmaceuticals Canada Inc. (Sunovion Pharmaceuticals Canada), formerly Sepracor Pharmaceuticals, Inc., announced today that it has formally changed its name.  The change occurs as a result of the continued integration of Sunovion Pharmaceuticals Inc. (the U.S.-based parent company of Sunovion Pharmaceuticals Canada) and Dainippon Sumitomo Pharma Co., Ltd. (DSP), a multi-national pharmaceutical company located in Osaka, Japan. The majority of DSP's operations in North America and certain strategic international locations will now carry the Sunovion name.

"The name Sunovion represents two timeless forces: the strength of the sun and the power of human innovation. Together they represent the life affirming energy that drives our vision and inspires our people, who strive to realize that vision every day," said Douglas Reynolds, President, Sunovion Pharmaceuticals Canada.  "As part of a growing global organization, this is an exciting time for Sunovion Pharmaceuticals Canada and, we look forward to expanding our product portfolio in the years ahead with potential launches in the areas of psychiatry and neurology."